JCR Pharmaceuticals Announces 52-Week Interim Data from its Global Phase I/II Study of JR-171 in Individuals with Mucopolysaccharidosis Type I (MPS I)
- JCR to Host Webinar on October 4, 2023, to Present Further Details - HYOGO,…
- JCR to Host Webinar on October 4, 2023, to Present Further Details - HYOGO,…
BEIJING--(BUSINESS WIRE)--In order to promote international cooperation and the trade development of China's machinery and…
BANGKOK, THAILAND - Media OutReach - 29 September 2023 - Arçelik Hitachi Home Appliances today…
Jurisdictions including Hong Kong are rolling out new rules and guidance for asset managers in…
This year’s theme ‘Go Global from the Get Go’ sets the tone for a 2-day…
Named Best Logistics Service Provider - Sea for the Third Time HONG KONG SAR -…
SINGAPORE--(BUSINESS WIRE)--OrBit Markets, the leading institutional liquidity provider in digital asset options and structured derivatives,…
HONG KONG SAR - Media OutReach - 29 September 2023 - Lever Style Corp ("Lever…
HONG KONG SAR - Media OutReach - 29 September 2023 - A recent survey conducted…
New equity fund will make growth equity investments in tech and tech-enabled mid to late-stage…